KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Net Cash Flow (2016 - 2025)

Rigel Pharmaceuticals has reported Net Cash Flow over the past 16 years, most recently at -$8.0 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 257.38% year-over-year to -$8.0 million; the TTM value through Dec 2025 reached -$16.1 million, down 167.23%, while the annual FY2025 figure was -$16.1 million, 167.23% down from the prior year.
  • Net Cash Flow for Q4 2025 was -$8.0 million at Rigel Pharmaceuticals, down from -$4.9 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $64.8 million in Q2 2021 and troughed at -$54.4 million in Q3 2021.
  • A 5-year average of $513200.0 and a median of -$438000.0 in 2022 define the central range for Net Cash Flow.
  • On a YoY basis, Net Cash Flow climbed as much as 839.79% in 2021 and fell as far as 55630.61% in 2021.
  • Year by year, Net Cash Flow stood at -$11.5 million in 2021, then soared by 53.04% to -$5.4 million in 2022, then tumbled by 133.55% to -$12.6 million in 2023, then skyrocketed by 140.02% to $5.1 million in 2024, then plummeted by 257.38% to -$8.0 million in 2025.
  • Business Quant data shows Net Cash Flow for RIGL at -$8.0 million in Q4 2025, -$4.9 million in Q3 2025, and $7.7 million in Q2 2025.